300685.SZ
艾德生物
SZSE · Healthcare · C 制造业 · CN
CNY 18.41
−3.05%Margins
Gross margin
82.4%
EBITDA margin
39.8%
EBIT margin
34.9%
Net margin
30.0%
FCF margin
25.0%
17.3%
Return on equity
14.8%
Return on assets
18.4%
Return on invested capital
0.50x
Asset turnover
CNY 368.9M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026